EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Treace Medical Concepts, Inc. (TMCI) had EBIT Margin of -25.46% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$212.69M |
|
$-59.00M |
|
$42.94M |
|
$169.75M |
|
$266.84M |
|
$-54.15M |
|
$-4.85M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-59.00M |
|
$-54.15M |
|
$-43.36M |
|
63.27M |
|
63.27M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$132.05M |
|
$29.75M |
|
$58.53M |
|
$190.58M |
|
$30.64M |
|
$55.58M |
|
$72.61M |
|
$103.25M |
|
$87.33M |
|
$67.39M |
|
$87.33M |
|
63.86M |
|
| Cash Flow Statement Financials | |
$-15.97M |
|
$13.25M |
|
$2.08M |
|
$11.35M |
|
$10.71M |
|
$-0.64M |
|
$33.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.31 |
|
-- |
|
-- |
|
0.39 |
|
0.64 |
|
79.81% |
|
-25.46% |
|
|
EBIT Margin |
-25.46% |
-20.39% |
|
-27.74% |
|
-27.74% |
|
$-29.49M |
|
-- |
|
-- |
|
-- |
|
1.12 |
|
1.19 |
|
5.05 |
|
72.34 |
|
-67.56% |
|
-87.55% |
|
-30.96% |
|
-41.28% |
|
$1.37 |
|
$-0.47 |
|
$-0.25 |
|